Acclinate Logo
Talk to Our Team
DPHARM Idol is an annual competition that recognizes disruptive companies on their technologies and services for their quality, especially for the benefit of patients for the pharma and healthcare industry.

Acclinate had six minutes to present to DPHARM Idol Disrupt’s judges, followed by a rigorous Q&A.

“The core of what Acclinate is addressing is increasing trust, particularly with communities of color,” said Dr. Smith. “It is about engaging with the individual before they become a patient, going further upstream in the process to do the work necessary to build trust.”

To learn more about the competition, read the press release

Recent Posts

Keep Personalization Alive: Building Scalable Tech That Serves Every Community
4 Min Read

When I think about the role of technology in healthcare, I feel both excited and cautious. Excited, because scaling technology means we can reach more...

Read More
Improve Diversity in Clinical Trials Without Slowing Progress
4 Min Read

Key Takeaways and Learnings The belief that representation slows clinical trials is outdated—early inclusion strategies often speed them up. Retention...

Read More
Why Diverse Clinical Trials Yield Smarter, Safer Science
4 Min Read

Key Takeaways and Learnings Diverse clinical trials yield smarter, safer science by making results more generalizable and interventions more effective...

Read More
Turning Data Into Direction: Business Intelligence as a Catalyst for Inclusive Research
3 Min Read

I learned to respect business intelligence (BI) in hospitals and health systems, where every decision felt urgent and the stakes were always high. In ...

Read More
6 Proven Strategies for Representative Trial Recruitment
5 Min Read

Key Takeaways and Learnings One-size-fits-all efforts don’t result in inclusive participant outreach plans that work. Predictive analytics, community ...

Read More
Reduce Recruitment Risk in Pharma Through Representation
4 Min Read

Key Takeaways and Learnings Underrepresentation slows recruitment, increases dropout risk, and weakens data reliability. Proactive inclusion strategie...

Read More
Beyond Compliance: Building Trust Through Robust Data Security and Ethical Practices
3 Min Read

In clinical research, data is everything. It’s the foundation of scientific discovery, the evidence behind regulatory approvals, and the key to develo...

Read More
How to Reach Diverse Patients for Clinical Trials—and Engage Them
5 Min Read

Key Takeaways and Learnings Traditional “one-size-fits-all” recruitment fails to address the barriers and concerns of underrepresented communities. Or...

Read More
What FDA Diversity Guidance Means for Your Next Trial
3 Min Read

Key Takeaways and Learnings Over the past few years, FDA diversity guidance has recommended early, structured inclusion planning. Despite shifting pol...

Read More